EHA - José Carreras Foundation Young Investigator Fellowship
The EHA - José Carreras Foundation Young Investigator Fellowship Program provides seed funds to promising young investigators to encourage and promote quality research in hematology. The fellowship is sponsored through the EHA via unrestricted educational grants from the three European José Carreras Foundations: José Carreras International Leukemia Foundation, Fondation José Carreras pour la lutte contre la leucèmie, Genève and Deutsche José Carreras Leukämie Stiftung e.V.
|
|
|
Winner
|
|
Institution
|
|
Project title
|
|
2000
|
|
Ingo Tamm,
Germany
|
|
Humboldt University Berlin
|
|
Prognostic Significance of Apoptosis-Regulating Proteins in Leukemia.
|
|
2001
|
|
L. Di Croce,
Italy
|
|
European Institute of Oncology
|
|
Molecular genetics of acute myeloid leukemias.
|
|
2002
|
|
E. van den Akker,
The Netherlands
|
|
Erasmus University Medical Center Rotterdam
|
|
Dissection of the role of Evil in myeloid leukemia using conditional in vitro and in vivo models.
|
|
2003
|
|
A. Benecke,
France
|
|
Inserm – U417
|
|
Epigenomics of myelopoiesis and acute promyelocytic leukemia.
|
|
2004
|
|
Jan Cools,
Belgium
|
|
University Hospital Gasthuisberg Leuven
|
|
A micro-array approach towards the detection of novel cryptic chromosomal rearrangements involving protein tyrosine kinases.
|
|
2005
|
|
Brian Huntly,
United Kingdom
|
|
Cambridge Institute for Medical Reserach
|
|
Characterisation of the molecular mechanisms of self-renewal in leukaemic stem cells.
|
EHA Research Fellowships
The EHA research fellowships are aimed at promoting hematological research and target young basic and clinical researchers both in the field of malignant and non-malignant hematology. The research fellowships are fully sponsored by the European Hematology Association and designed to support salary, supplies, equipment and travel necessary for the pursuit of the recipient's research project.
|
|
|
Winner
|
|
Institution
|
|
Project title
|
|
2004
|
|
Meritxell Jorda, The Netherlands
|
|
Erasmus MC Rotterdam
|
|
Expression and function of alpha E-catenin, a novel CEBP? target gene, in normal hematopoiesis and leukemia.
|
|
2004
|
|
Kathleen Freson, Belgium
|
|
University of Leuven
|
|
Hematopoietic stem cell-based gene therapy for hereditary thrombocytopenia due to gata-1 deficiency.
|
|
2005
|
|
Attilio Bondanza, Italy
|
|
Fondazione Centro S. Raffaele del Monte Tabor
|
|
Safe and effective immunotherapy of Leukaemia with suicide-modified lymphocytes retaining minor HLA-specific alloreactivity.
|
|
2005
|
|
François Delhommeau, France
|
|
Hôpital Hotel Dieu
|
|
Involvement of the V617F JAK2 mutation in Polycythaemia Vera, Essential Thrombocythaemia and Idiopathic Myelofibrosis. Consequences of the mutation in human haematopoiesis.
|
|
2005
|
|
Ton Lisman, The Netherlands
|
|
UMC Utrecht
|
|
Hypofibrinolysis and the risk of a first episode of venous thrombosis.
|
|
2005
|
|
Ralf Schmidmaier, Germany
|
|
University Hospital Munich
|
|
Targeting integrin mediated survival in multiple myeloma.
|
EHA Clinical Research Grants
These grants have been established to promote clinical research in patients with hematological diseases, e.g. to support logistics of translational research, phase I, II or III clinical trials, support of research nurses, data-managers, etc. They are not intented for primarily laboratory research. The grants will provide financial support for salaries, supplies, equipment and travel necessary for the project.
|
|
|
Winner
|
|
Institution
|
|
Project title
|
|
2004
|
|
Philippe Guardiola, France
|
|
Hospital Saint Louis
|
|
A prospective 2X2 randomized multicenter study evaluating the role of remission-induction and consolidation chemotherapy prior to allogeneic transplantation and of G-CSF mobilized peripheral blood progenitor vells versus bone marrow stem cells using HLA-identical siblings in patients less than 50 years of age with myelodysplastic syndromes and 5% to 20% bone marrow blasts .
|
|
2004
|
|
Francesco Forconi, Italy
|
|
Policlinico Le Scotte, Azienda Ospedaliera Senese
|
|
Insight in the pathogenesis and behavior of hairy cell leukemia from immunogenetic analysis.
|
|
2005
|
|
Alessandro Isidori, Italy
|
|
University of Bologna -"La Seragnoli"
|
|
Adoptive immunotherapy of high risk AML using haploidentical KIR-mismatched NK cells.
|
|
2005
|
|
Ann Van de Velde, Belgium
|
|
Antwerp University Hospital
|
|
WT1 mRNA-transfected autologous DC vaccination for patients with AML.
|
Tip a colleague ] [
Print view ]